Co-Administration of Generic Drugs and Medical Foods
In clinical practice, physicians prescribe treatment based on the patient’s best interest. In practice, one size frequently does not fit all. Doses or levels of therapy need to be adjusted based on the severity of illness or other metabolic characteristics of the patient’s underlying condition. Employing a therapeutic range provides physicians with the flexibility to titrate and optimize therapy for an individual patient. The pairing of a Medical Food with a drug allows ease of dose titration to therapeutic regime and results in an optimal drug dosage over a variable period of time.
Medical Foods such as GABAdone®, Sentra PM®, Theramine® and Pulmona® can be used as a standalone therapy, or Co-administered with pharmaceutical agents used conventionally in the practice of medicine. Clinical evidence demonstrates that medical food products based on Targeted Cellular Technology can selectively stimulate the production of neurotransmitters with the desired, consistent physiological responses. This effect occurs with low doses of amino acids, and does not attenuate with repeated or continuous use. The co-administration of a Medical Food and a generic drug provides physicians with a targeted disease management platform to optimize drug dose for specific patients with a specific disease.
